| Literature DB >> 30998425 |
Thomas R O'Brien1, Howard A Young2, Raymond P Donnelly3, Ludmila Prokunina-Olsson4.
Abstract
A meeting entitled, "Interferon Lambda: Disease Impact and Translational Potential," was held on the campus of the National Institutes of Health in Bethesda, Maryland, on October 25-26, 2018. To our knowledge, this was the first meeting that focused exclusively on interferon lambda (IFN-λ). The meeting's purpose was to enhance interdisciplinary communication and promote new collaborations. The gathering brought together an international group of scientists from a wide range of disciplines. Sessions included: IFN-λ Biology, Therapy and Genetic Variation; IFN-λ and Hepatitis C Virus Infection; IFN-λ in Other Infections; and IFN-λ-Hepatic Fibrosis and Cancer. The next meeting on IFN-λ is planned for 2020.Entities:
Keywords: cancer; genetics; hepatitis C virus; immunology; infectious diseases; interferon lambda
Mesh:
Substances:
Year: 2019 PMID: 30998425 PMCID: PMC6767859 DOI: 10.1089/jir.2019.0018
Source DB: PubMed Journal: J Interferon Cytokine Res ISSN: 1079-9907 Impact factor: 2.607